UPDATE: Stifel Nicolaus Initiates CareFusion at Buy on Post-Spin Transformation Outlook
Stifel Nicolaus initiated coverage on CareFusion (NYSE: CFN) with a Buy rating and a $33 price target.
Stifel Nicolaus commented, "We are initiating coverage of CareFusion Corp. (CFN) with a Buy rating and $33 target price, reflecting a 13x multiple on CY14E EPS of $2.54 (excluding amortization). CFN remains in the early innings of a compelling multi-year margin expansion and EPS growth acceleration story. Importantly, CFN's margin expansion is not solely predicated on revenue growth acceleration, but also internally driven cost reduction and business realignment initiatives. We view CFN shares as inexpensive relative to industry valuation averages."
CareFusion closed at $26.77 on Monday.
Latest Ratings for CFN
|Oct 2014||Raymond James||Downgrades||Strong Buy||Market Perform|
|Oct 2014||JP Morgan||Downgrades||Overweight||Neutral|
|Oct 2014||Piper Jaffray||Downgrades||Overweight||Neutral|
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.